Sonneveld, P., Hillengaß, J., & Goldschmidt, H. (2016). Treatment of multiple myeloma with high-risk cytogenetics: A consensus of the International Myeloma Working Group. Blood, 127(24), . https://doi.org/10.1182/blood-2016-01-631200
Chicago Style (17th ed.) CitationSonneveld, Pieter, Jens Hillengaß, and Hartmut Goldschmidt. "Treatment of Multiple Myeloma with High-risk Cytogenetics: A Consensus of the International Myeloma Working Group." Blood 127, no. 24 (2016). https://doi.org/10.1182/blood-2016-01-631200.
MLA (9th ed.) CitationSonneveld, Pieter, et al. "Treatment of Multiple Myeloma with High-risk Cytogenetics: A Consensus of the International Myeloma Working Group." Blood, vol. 127, no. 24, 2016, https://doi.org/10.1182/blood-2016-01-631200.
Warning: These citations may not always be 100% accurate.